Human Chorionic Gonadotropin (hCG) Research for Cryptorchidism
An evidence-based overview of research examining Human Chorionic Gonadotropin (hCG) in the context of cryptorchidism. This page synthesizes findings from peer-reviewed literature.
Research Summary
hCG has FDA approval for cryptorchidism in prepubertal males. While meta-analyses show approximately 19% success rate for testicular descent, surgical orchiopexy is now preferred as first-line treatment due to higher efficacy.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Human Chorionic Gonadotropin (hCG) may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.